Is It Too Late to Buy Eli Lilly?
The stock has soared 400% in recent years.
Overview
Eli Lilly (NYSE: LLY) stock has been winning big when it comes to earnings and stock performance in recent years. And this has a lot to do with the company's leadership in a type of drug that's taken the world by storm: GLP-1 drugs for weight loss. Lilly dominates the market, and its drugs have been bringing in blockbuster revenue.
With the obesity drug market on track to reach nearly $100 billion by the end of the decade, the success story may be far from over. Still, Lilly stock has climbed 400% over the past five years and now trades for more than $1,200. Is it too late to get in on shares of the pharma giant? Let's find out.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.